Quantative Composition
Formula when powder dissolved in water:
Anhydrous calcium lactate, 0.0436 g: anhydrous magnesium sulphate, 0.024 g: anhydrous
citric acid, 0.032 g: anhydrous sodium citrate, 0.258g: anhydrous sodium chloride, 0.0585
g: anhydrous potassium chloride, 0.149 g: anhydrous sodium phosphate, 0.071 g:
anhydrous glucose, 5g.
Additives: Neohesperdine, Orange flavour and yellow-orange colouring (E-110)
Formula of the solution expressed in mEq:
Lactate 0.4 mEq; Sulphate 0.4 mEq; Citrate 3.5 mEq; Phosphate 1 mEq; Chloride, 3 mEq;
Calcium 0.4mg; Sodium 5 mEq; Magnesium 0.4 mEq; Potassium 2mEq; anhydrous glucose
5g (20 Calories).
Additives: Neohesperdine, Orange flavour and yellow-orange colouring (E-110)
Indications:
Acute diarrhoea in babies; as a prophylaxis and treatment for states of moderate
dehydration; acidosis or vomiting; in extra-renal uremia and in general for all cases of
profuse fluid loss through persistent diarrhoea or vomiting; hyperemesis gravidarum etc
Posology:
To be taken orally. In drink form, until complete rehydration is judged to be achieved.
Counterindications and Precautions:
Must be used with caution in diabetics and patients with parasitic infestations. Serious or
persistent diarrhoea, or other critical losses of fluids which require parenteral therapy:
continuous vomiting, paralytic ileus, intestinal obstruction or perforation; diminished renal
function (anuria, oliguria).
Warning
This medicine contains 5g of anhydrous glucose in every 100ml of reconstituted solution,
which must be taken into account when dealing with diabetic patients.
Warning re: additives
The medicine contains yellow orange colouring S (E-110) as a non-clinical additive. It can
cause allergic reactions including asthma, especially in patients allergic to Acetylsalicylic acid.
Incompatibilities
It is not advisable to mix CITORSAL with milk, fruit juice or other liquids containing
electrolytes; if the administration of more liquid is required, water should be used. The
product interferes with the absorption of tetracycline.
Side effects
Used at recommended dilution, no side effects have been described.
Overdose and its treatment
There have been no known cases of overdose in this product.
In case of overdose or accidental ingestion, please consult the Servicio de Informacion
Toxicologica Tel 91/562-04-20
Presentation and Prices
Pack containing 2 sachets of soluble powder P.V.P. IVA 1.69E C.N. 853499
Pack containing 5 sachets of soluble powder P.V.P. IVA 3.73E C.N. 827378
Instructions for correct administration
Each sachet should be dissolved in ½ litre of water: or two sachets in one litre. To make the
dissolution process easier, we recommend the powder is added slowly to the water whilst
vigorously stirring until it has completely dissolved. In certain conditions, which have no
effect on the products therapeutic qualities, CITORSAL may harden in the packet. In this
case, simply press on the bag until the CITORSAL is reduced to a fine, soluble powder.
Conditions of Prescription and Dispensation
With medical prescription. Can be financed by S.N.S. S.N.S subsidy at normal rate.
Laboratorios ERN SA
Pedro IV, 499-08020 Barcelona, España